ReproCELL Incorporated
Status: Publicly traded
Direct answer
ReproCELL Incorporated is publicly traded on JPX under the ticker 4978.T.
Established in 2003 and headquartered in Yokohama, Japan, ReproCELL Incorporated operates as a prominent firm specializing in stem cell research. The company furnishes an extensive portfolio of products crucial for various stem cell applications, including a diverse array of specialized reagents for RNA reprogramming, cell growth (such as small molecules, growth factors, and cytokines), cell characterization (like...
Can you invest in ReproCELL Incorporated?
Yes. ReproCELL Incorporated trades publicly on JPX as 4978.T.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for ReproCELL Incorporated
Detailed equity research is provided by MarketSnap.